The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

First-in-Man Percutaneous Closure of Left Atrial Appendage Using Ultraseal II Device

EuroIntervention 2019; just accepted article published in May 2019. DOI: 10.4244/EIJ-D-18-01084

1. Servicio de Cardiología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Facultad de Medicina, Universidad de Salamanca, y CIBERCV, Salamanca, España.; 2. Servicio de Cardiologica, Hospital Universitario de Salamanca, Instituto de Investigación Biomedical de Salamanca (IBSAL), Faulted de Medicina, Universidad de Salamanca, Y CIBERCV, Salamanca, Espana, SPAIN; 3. Servicio de Cardiología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Facultad de Medicina, Universidad de Salamanca, y CIBERCV, Salamanca, España.; 4. Servicio de Cardiología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Facultad de Medicina, Universidad de Salamanca, y CIBERCV, Salamanca, España.
Disclaimer:

As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers.

To read the full content of this article, please log in to download the PDF.

Here we describe the first implantation of the Ultraseal II device for the percutaneous closure of the left appendage in an 74 year-old man with nonvalvular atrial fibrillation and contraindication to oral anticoagulation, performed under conscious sedation and less invasive echocardiographic imaging using the microtransoesophageal echocardiographic guidance. The device was successfully deployed, without residual peridevice flow into the left atrial appendage after closure and without peri-procedural complications. The novel Ultraseal II device presents different aspects of improvement, wich make the device easier to deploy and recapture, and adaptable to different left atrial appendage morphologies.

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Pulmonary hemodynamic effects of interatrial shunt in heart failure with preserved ejection fraction in rats